Search Results - Gordon, Stuart C

Refine Results
  1. 1
    Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy

    Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy by Gordon, Stuart C.

    Published 2011
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Polycystic Liver Disease

    Polycystic Liver Disease by Gordon, Stuart C.

    Published 2015
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Hepatitis C Virus Detection and Treatment in Rural Communities

    Hepatitis C Virus Detection and Treatment in Rural Communities by Gordon, Stuart C.

    Published 2018
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Update on Polycystic Liver Disease

    Update on Polycystic Liver Disease by Gordon, Stuart C.

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Epidemiology of Hepatitis C

    Epidemiology of Hepatitis C by Jafri, Syed‐Mohammed, Gordon, Stuart C.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Is there still a role for liver biopsy in managing hepatitis C virus infections?

    Is there still a role for liver biopsy in managing hepatitis C virus infections? by Jafri, Syed‐Mohammed R., Gordon, Stuart C.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Management of Direct‐Acting Antiviral Failures

    Management of Direct‐Acting Antiviral Failures by Alimirah, Maryam, Sadiq, Omar, Gordon, Stuart C.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Response to: ‘No impact of Covid‐19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan’

    Response to: ‘No impact of Covid‐19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan’ by Gonzalez, Humberto C., Rupp, Loralee B., Trudeau, Sheri, Gordon, Stuart C.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma

    A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma by Gish, Robert G., Gordon, Stuart C., Nelson, David, Rustgi, Vinod, Rios, Israel

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care

    Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care by Younossi, Zobair M., Park, Haesuk, Dieterich, Douglas, Saab, Sammy, Ahmed, Aijaz, Gordon, Stuart C.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score

    Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score by Gordon, Stuart C., Kachru, Nandita, Parker, Emily, Korrer, Stephanie, Ozbay, A. Burak, Wong, Robert J.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records

    Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records by Lu, Mei, Chacra, Wadih, Rabin, David, Rupp, Loralee B, Trudeau, Sheri, Li, Jia, Gordon, Stuart C

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis

    A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis by Columbus-Morales, Ivan, Maahs, Lucas, Husain, Sanam, Gordon, Stuart C., Inamdar, Kedar V., Gonzalez, Humberto C.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases

    Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases by Wong, Robert J., Kachru, Nandita, Martinez, Diane J., Moynihan, Meghan, Ozbay, A. Burak, Gordon, Stuart C.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials

    Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials by Tran, Tram T., Gordon, Stuart C., Fung, Scott, Dinh, Phillip, Yee, Leland, Martins, Eduardo Bruno, Buti, Maria, Marcellin, Patrick

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Baricitinib and primary biliary cholangitis

    Baricitinib and primary biliary cholangitis by Gordon, Stuart C., Trudeau, Sheri, Regev, Arie, Uhas, Jonathan M., Chakladar, Sujatro, Pinto-Correia, Ana, Gottlieb, Klaus, Schlichting, Doug

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Differences in Hepatic Phenotype Between Hemochromatosis Patients with HFE C282Y Homozygosity and Other HFE Genotypes

    Differences in Hepatic Phenotype Between Hemochromatosis Patients with HFE C282Y Homozygosity and Other HFE Genotypes by Cheng, Raymond, Barton, James C., Morrison, Elizabeth D., Phatak, Pradyumna D., Krawitt, Edward L., Gordon, Stuart C., Kowdley, Kris V.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B

    Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B by Nguyen, Mindie H., Lim, Joseph K., Burak Ozbay, A., Fraysse, Jeremy, Liou, Iris, Meyer, Nicole, Dusheiko, Geoffrey, Gordon, Stuart C.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006–2010

    Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006–2010 by Allison, Robert D., Tong, Xin, Moorman, Anne C., Ly, Kathleen N., Rupp, Loralee, Xu, Fujie, Gordon, Stuart C., Holmberg, Scott D.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States

    Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States by Chhatwal, Jagpreet, Chen, Qiushi, Ayer, Turgay, Bethea, Emily D., Kanwal, Fasiha, Kowdley, Kris V., Wang, Xiaojie, Roberts, Mark S., Gordon, Stuart C.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: